Stephen D. Gillies

Person

Carlisle, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Humanized and de-immunized antibodies
- Patent number 12,043,659
- Issue date Jul 23, 2024
- VIVORYON THERAPEUTICS N.V.
- Jens-Ulrich Rahfeld
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PD-L1 and IL-2 cytokines
- Patent number 11,965,026
- Issue date Apr 23, 2024
- Kymab Limited
- Jamie Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Light chain immunoglobulin fusion proteins and methods of use thereof
- Patent number 11,492,383
- Issue date Nov 8, 2022
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TIGIT antibodies, encoding nucleic acids and methods of using said...
- Patent number 11,440,960
- Issue date Sep 13, 2022
- Kymab Limited
- Joana de Abreu Carvalho
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies
- Patent number 11,045,533
- Issue date Jun 29, 2021
- PROBIODRUG AG
- Martin Kleinschmidt
- G01 - MEASURING TESTING
Information Patent Grant
Anti-cancer antibodies with reduced complement fixation
- Patent number 10,633,452
- Issue date Apr 28, 2020
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies and immunocytokines
- Patent number 10,604,576
- Issue date Mar 31, 2020
- Kymab Limited
- Jamie Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized antibodies
- Patent number 10,603,367
- Issue date Mar 31, 2020
- Probiodrug AG
- Martin Kleinschmidt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cancer antibodies with reduced complement fixation
- Patent number 10,017,579
- Issue date Jul 10, 2018
- Meck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ICOS antibodies
- Patent number 9,957,323
- Issue date May 1, 2018
- Kymab Limited
- Richard Charles Alfred Sainson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cancer antibodies with reduced complement fixation
- Patent number 9,617,349
- Issue date Apr 11, 2017
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies and immunocytokines
- Patent number 9,617,338
- Issue date Apr 11, 2017
- Kymab Limited
- Jamie Campbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies and immunocytokines
- Patent number 9,567,399
- Issue date Feb 14, 2017
- Kymab Limited
- Jamie Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy using anti-EGFR and anti-HER2 antibodies
- Patent number 9,522,956
- Issue date Dec 20, 2016
- L'Institut National de la Sante et de la Recherche Medicale
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Reducing the immunogenicity of fusion proteins
- Patent number 8,926,973
- Issue date Jan 6, 2015
- Merck Patent GmbH
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cancer antibodies with reduced complement fixation
- Patent number 8,835,606
- Issue date Sep 16, 2014
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Expression and export of angiogenesis inhibitors as immunofusins
- Patent number 8,703,908
- Issue date Apr 22, 2014
- Merck Patent GmbH
- Kin-Ming Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilization of Fc-interferon-beta fusion proteins
- Patent number 8,557,232
- Issue date Oct 15, 2013
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunocytokine sequences and uses thereof
- Patent number 8,470,991
- Issue date Jun 25, 2013
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interleukin-12 targeted to oncofoetal fibronectin
- Patent number 8,420,087
- Issue date Apr 16, 2013
- Antisoma Research Limited
- Stephen Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD20-binding polypeptide compositions for treating autoimmune disease
- Patent number 8,337,844
- Issue date Dec 25, 2012
- Merck Patent GmbH
- Francis Joseph Carr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IL-7 fusion proteins
- Patent number 8,338,575
- Issue date Dec 25, 2012
- Merck Patent GmbH
- Scott Lauder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Expression and export of angiogenesis inhibitors as immunofusins
- Patent number 8,206,718
- Issue date Jun 26, 2012
- Merck Patent GmbH
- Kin-Ming Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD20-binding polypeptide compositions and methods
- Patent number 8,147,832
- Issue date Apr 3, 2012
- Merck Patent GmbH
- Francis Joseph Carr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteins comprising an IgG2 domain
- Patent number 8,066,994
- Issue date Nov 29, 2011
- Merck Patent GmbH
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of using Fc-cytokine fusion proteins
- Patent number 8,043,608
- Issue date Oct 25, 2011
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Reducing the immunogenicity of fusion proteins
- Patent number 7,973,150
- Issue date Jul 5, 2011
- Merck Patent GmbH
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IL-7 fusion proteins
- Patent number 7,960,514
- Issue date Jun 14, 2011
- Merck Patent GmbH
- Scott Lauder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fc fusion proteins for enhancing the immunogenicity of protein and...
- Patent number 7,955,590
- Issue date Jun 7, 2011
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding IL-2 fusion proteins with modulated selectivity
- Patent number 7,888,071
- Issue date Feb 15, 2011
- Merck Patent GmbH
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
LIGHT CHAIN IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF USE THEREOF
- Publication number 20240076341
- Publication date Mar 7, 2024
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY
- Publication number 20230192859
- Publication date Jun 22, 2023
- Kymab Limited
- Jamie CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-ICOS ANTIBODIES
- Publication number 20220403029
- Publication date Dec 22, 2022
- Kymab Limited
- Richard Charles Alfred SAINSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ICOS ANTIBODIES
- Publication number 20220380467
- Publication date Dec 1, 2022
- Kymab Limited
- Richard Charles Alfred SAINSON
- G01 - MEASURING TESTING
Information Patent Application
INFLUENZA VACCINES AND METHODS OF USE THEREOF
- Publication number 20220073648
- Publication date Mar 10, 2022
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PD-L1 ANTIBODIES
- Publication number 20210380699
- Publication date Dec 9, 2021
- Kymab Limited
- Jamie CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED AND DE-IMMUNIZED ANTIBODIES
- Publication number 20210032315
- Publication date Feb 4, 2021
- VIVORYON THERAPEUTICS AG
- Jens-Ulrich RAHFELD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODY WITH COMBINATION THERAPY FOR IMMUNO-ONCOLOGY
- Publication number 20200190191
- Publication date Jun 18, 2020
- KYMAB LIMITED
- Jamie Iain CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTIBODIES
- Publication number 20200138922
- Publication date May 7, 2020
- PROBIODRUG AG
- Martin Kleinschmidt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES
- Publication number 20200131267
- Publication date Apr 30, 2020
- Kymab Limited
- Joana de Abreu CARVALHO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PD-L1 ANTIBODIES
- Publication number 20190330351
- Publication date Oct 31, 2019
- KYMAB LIMITED
- Jamie CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-ICOS ANTIBODIES
- Publication number 20190330345
- Publication date Oct 31, 2019
- KYMAB LIMITED
- Richard Charles Alfred SAINSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY
- Publication number 20190202917
- Publication date Jul 4, 2019
- KYMAB LIMITED
- Jamie CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CANCER ANTIBODIES WITH REDUCED COMPLEMENT FIXATION
- Publication number 20190031769
- Publication date Jan 31, 2019
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTIBODIES
- Publication number 20180140689
- Publication date May 24, 2018
- PROBIODRUG AG
- Martin Kleinschmidt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ICOS ANTIBODIES
- Publication number 20180066058
- Publication date Mar 8, 2018
- Kymab Limited
- Richard Charles Alfred SAINSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AND IMMUNOCYTOKINES
- Publication number 20170362321
- Publication date Dec 21, 2017
- Kymab Limited
- Jamie Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-Cancer Antibodies With Reduced Complement Fixation
- Publication number 20170210817
- Publication date Jul 27, 2017
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INFLUENZA VACCINES AND METHODS OF USE THEREOF
- Publication number 20170198061
- Publication date Jul 13, 2017
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REDUCING THE IMMUNOGENICITY OF FUSION PROTEINS
- Publication number 20150141626
- Publication date May 21, 2015
- Merck Patent GmbH
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Therapy Using Anti-EGFR And Anti-HER2 Antibodies
- Publication number 20150132308
- Publication date May 14, 2015
- L'Institut National De La Sante Et De La Recherche Medicale
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-Cancer Antibodies With Reduced Complement Fixation
- Publication number 20150065691
- Publication date Mar 5, 2015
- Merck Patent GmbH
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LIGHT CHAIN IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF USE THEREOF
- Publication number 20140294758
- Publication date Oct 2, 2014
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FC-Interferon-Beta Fusion Proteins
- Publication number 20140005361
- Publication date Jan 2, 2014
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXPRESSION AND EXPORT OF ANGIOGENESIS INHIBITORS AS IMMUNOFUSINS
- Publication number 20130165634
- Publication date Jun 27, 2013
- Merck Patent GmbH
- Kin-Ming Lo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR ENHANCING THE EFFICACY OF IL-2 MEDIATED IMMUNE RESPONSES
- Publication number 20130017168
- Publication date Jan 17, 2013
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REDUCING THE IMMUNOGENICITY OF FUSION PROTEINS
- Publication number 20120309936
- Publication date Dec 6, 2012
- Merck Patent GmbH
- Stephen D. Gillies
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD20-Binding Polypeptide Compositions and Methods
- Publication number 20120183545
- Publication date Jul 19, 2012
- Merck Patent GmbH
- Francis Joseph Carr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-7 FUSION PROTEINS
- Publication number 20110243887
- Publication date Oct 6, 2011
- Merck Patent GmbH
- Scott Lauder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-6 ANTAGONISTS
- Publication number 20110038877
- Publication date Feb 17, 2011
- Merck Patent GmbH
- Jeffrey Way
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Stephen D. Gillies

Person

Patents Grantslast 30 patents

Humanized and de-immunized antibodies

Anti-PD-L1 and IL-2 cytokines

Light chain immunoglobulin fusion proteins and methods of use thereof

TIGIT antibodies, encoding nucleic acids and methods of using said...

Humanized antibodies

Anti-cancer antibodies with reduced complement fixation

Antibodies and immunocytokines

Humanized antibodies

Anti-cancer antibodies with reduced complement fixation

Anti-ICOS antibodies

Anti-cancer antibodies with reduced complement fixation

Antibodies and immunocytokines

Antibodies and immunocytokines

Combination therapy using anti-EGFR and anti-HER2 antibodies

Reducing the immunogenicity of fusion proteins

Anti-cancer antibodies with reduced complement fixation

Expression and export of angiogenesis inhibitors as immunofusins

Stabilization of Fc-interferon-beta fusion proteins

Immunocytokine sequences and uses thereof

Interleukin-12 targeted to oncofoetal fibronectin

CD20-binding polypeptide compositions for treating autoimmune disease

IL-7 fusion proteins

Expression and export of angiogenesis inhibitors as immunofusins

CD20-binding polypeptide compositions and methods

Proteins comprising an IgG2 domain

Methods of using Fc-cytokine fusion proteins

Reducing the immunogenicity of fusion proteins

IL-7 fusion proteins

Fc fusion proteins for enhancing the immunogenicity of protein and...

DNA encoding IL-2 fusion proteins with modulated selectivity

Patents Applicationslast 30 patents

LIGHT CHAIN IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF USE THEREOF

MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY

ANTI-ICOS ANTIBODIES

ANTI-ICOS ANTIBODIES

INFLUENZA VACCINES AND METHODS OF USE THEREOF

ANTI-PD-L1 ANTIBODIES

HUMANIZED AND DE-IMMUNIZED ANTIBODIES

MULTISPECIFIC ANTIBODY WITH COMBINATION THERAPY FOR IMMUNO-ONCOLOGY

HUMANIZED ANTIBODIES

ANTIBODIES

ANTI-PD-L1 ANTIBODIES

ANTI-ICOS ANTIBODIES

MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY

ANTI-CANCER ANTIBODIES WITH REDUCED COMPLEMENT FIXATION

HUMANIZED ANTIBODIES

ANTI-ICOS ANTIBODIES

ANTIBODIES AND IMMUNOCYTOKINES

Anti-Cancer Antibodies With Reduced Complement Fixation

INFLUENZA VACCINES AND METHODS OF USE THEREOF

REDUCING THE IMMUNOGENICITY OF FUSION PROTEINS

Combination Therapy Using Anti-EGFR And Anti-HER2 Antibodies

Anti-Cancer Antibodies With Reduced Complement Fixation

LIGHT CHAIN IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF USE THEREOF

FC-Interferon-Beta Fusion Proteins

EXPRESSION AND EXPORT OF ANGIOGENESIS INHIBITORS AS IMMUNOFUSINS

METHODS FOR ENHANCING THE EFFICACY OF IL-2 MEDIATED IMMUNE RESPONSES

REDUCING THE IMMUNOGENICITY OF FUSION PROTEINS

CD20-Binding Polypeptide Compositions and Methods

IL-7 FUSION PROTEINS

INTERLEUKIN-6 ANTAGONISTS